Sleep

Not hours — architecture. What restores you is the order of the night: deep slow-wave sleep early for physical repair, REM weighted late for memory and emotion. A full eight hours in the wrong shape leaves you unrestored.

Training load increases it.

Systematic review/meta-analysis of RCTs finds exercise improves sleep quality and insomnia severity in adults (PMC8215288), replicated on the Pittsburgh Sleep Quality Index in older adults (PMC12528139). Honest caveat: not universal — the same MCI meta-analysis that showed a large cognitive gain found NO significant sleep improvement (SMD 0.07, p=0.94, PMC12753406), so the effect is population-dependent. Corroborated in older adults by PMC7559727 (37 RCTs, 3,224 participants; Hedges g 0.25-0.71 across outcomes including sleep quality). Scope, and it is narrow: the strongest sleep evidence sits in clinical populations — patients with depression, cognitive impairment, breast-cancer survivors, older adults — not healthy sleepers. Effect sizes are small to moderate. Subjective sleep improves more readily than objective sleep does. PMC8215288

Lowers cortisol reduces it.

HPA hyperactivity and disturbed sleep travel together: insomnia, depression, Cushing’s syndrome and sleep-disordered breathing all display HPA hyperactivity alongside disrupted sleep (PMC2902103), and elevated cortisol presents clinically as insomnia. Verified: loss of physiological cortisol suppression — elevated morning and bedtime cortisol — is linked to reduced hippocampal feedback sensitivity to glucocorticoids and leads to impaired stress recovery, sleep disturbances and metabolic dysfunction. The relationship runs both ways, and the source models the other direction explicitly: chronic sleep restriction itself produces physiologically relevant disruptions in the phase and amplitude of the cortisol rhythm (PMC8400645). Sleep loss and cortisol dysregulation drive each other. PMC2902103

Glycine calming increases it.

Primary is now objective, not subjective: Yamadera 2007, Sleep Biol Rhythms 5(2):126-131 (doi 10.1111/j.1479-8425.2007.00262.x) used polysomnography -- glycine before bed shortened PSG latency to sleep onset (p=0.01) and to slow-wave sleep, and improved sleep efficacy (sleep time / in-bed time), without altering sleep architecture. Participants had habitual unsatisfactory sleep, mean PSQI 8.07. It also lessened daytime sleepiness on the Stanford Sleepiness Scale and improved memory-recognition performance. The mechanism is NMDA receptors in the suprachiasmatic nucleus driving peripheral vasodilation and core-temperature fall (Kawai 2015, Neuropsychopharmacology 40(6):1405-1416, PMID 25533534). The limits ARE real and stated: n=11 (8 women, 3 men, 30-57), single-blinded crossover, and — decisively — all of the human trials come from one Japanese research group with NO large independent replication published. Under T4 (>=2 independent groups) this evidence cannot reach the top tier however good the method is. A 2024 systematic review of glycine in human adults exists (Soh 2024, GeroScience 46(1):219-239, PMID 37851316). doi 10.1111/j.1479-8425.2007.00262.x · PMID 25533534

Sleep pressure increases it.

Porkka-Heiskanen 1997, Science 276:1265 — adenosine accumulates during waking and inhibits arousal circuits, driving sleep pressure. PMID 9157887. Gain of function: pharmacologically raising adenosine in the basal forebrain, or giving A1 receptor agonists there, increases sleep. Loss of function: inactivating A1 receptors in the basal forebrain decreases EEG delta power and NREM sleep time. Mechanism: during prolonged waking, extracellular adenosine accumulates selectively in basal forebrain and cortex and restrains wake-promoting neurons via A1 — cholinergic cells in the basal forebrain, orexin cells in the lateral hypothalamus, histaminergic cells in the tuberomammillary nucleus. Caffeine is the proof running the other way: as an A1/A2A antagonist it removes adenosine's brake on orexin neurons and raises alertness. Two receptors, different circuits: A1 acts presynaptically and in the VLPO/median preoptic sleep circuits; A2A is Golf-coupled, enriched in striatum and nucleus accumbens, and works through the indirect basal-ganglia pathway. The basal forebrain contains A1 but not A2A receptors. And one arm is disputed at the receptor level: a 2025 study reports it saw neither inhibition of firing nor modulation of inhibitory potentials by adenosine in rat histaminergic neurons, and found NO A1 receptor in any histaminergic single-cell transcriptome database — concluding most histaminergic neurons ARE not inhibited by adenosine (PMC11711771). The cholinergic and orexinergic arms are secure; the histaminergic arm is contested. Species: rat and mouse. PMID 9157887 · PMC11711771

Lowers wake signal reduces it.

Chemelli 1999, Cell 98:437 — orexin/hypocretin stabilizes wakefulness; loss of orexin neurons causes narcolepsy. DOI 10.1016/s0092-8674(00)81973-x. Orexin/hypocretin neurons of the lateral hypothalamus are critical for wakefulness, and their loss causes narcolepsy. Causal in both directions in vivo: optogenetically activating GABAergic neurons inhibits orexin neurons and makes awake mice transition to sleep; conversely, microinjecting a selective adenosine A1 antagonist into the orexinergic lateral hypothalamus — removing adenosine's brake — produced a significant increase in wakefulness with reduced sleep, both spontaneously and during recovery sleep after 6 h deprivation (PMID 18440150). A precise limit from that same experiment: blocking the adenosine brake lengthened the latency to non-REM sleep but total slow-wave (delta) activity during recovery sleep was unaffected — orexin gates when you fall asleep, not how deeply you sleep once you do. Orexin also forms a wake-maintaining loop with glutamatergic neurons of the paraventricular thalamus. Species: rat and mouse. doi 10.1016/s0092-8674(00 · PMID 18440150

Sleep hormone increases it.

Melatonin, produced by the pineal gland at night, serves as a time CUE to the biological clock and promotes sleep anticipation via the brain default mode network, explaining increased sleep propensity in circadian rhythm sleep disorders. Scope, stated in the same literature: melatonin prevents arousal and promotes sleep -- but does not induce it (PMC6057894). It is a chronobiotic time signal, not a hypnotic, and should never be presented as one. PMC6057894

Calm increases it.

Gottesmann 2002, Neuroscience 111:231 — GABA-A receptor activation favors sleep; the target of every hypnotic drug class. PMID 11983310

Body clock increases it.

Cell-type-specific and causal: targeted deletion of the core clock gene BMAL1 in CaMK2a-expressing excitatory neurons of the medial prefrontal cortex disrupted sleep-wake architecture and elevated slow-wave activity. Not a correlation between rhythm and rest — remove one clock gene from one cell type and the structure of sleep changes. And at the master pacemaker: SCN Bmal1 knockdown shortened the period and dampened the amplitude of activity rhythms, while chronic optogenetic SCN stimulation at unpredictable times produced dampened, fragmented and unstable rhythms. It is not all of it: the note on sleep and mood records that one night of deliberate deprivation is antidepressant while chronic loss is not, and that homeostatic arm is not a clock phenomenon. PMID 27113500 · PMC12916475

Alertness chemical reduces it.

The noradrenergic locus coeruleus is a core wake-active nucleus of the ascending arousal system, sending arousing projections to thalamus and neocortex. The GABAergic VLPO neurons inhibit both the orexin system and the ascending arousal system; the arousal nuclei inhibit the VLPO back. A flip-flop has no comfortable middle — which is why sleep onset is abrupt rather than gradual, and why these arrows are drawn inhibitory as a class. And the causal test is cell-type-specific: ablating locus coeruleus norepinephrine neurons with SAPORIN conjugates attenuated the promotion of REM sleep by a dual orexin antagonist. That same experiment shows the the LC ablation affected REM only, and neither lesion altered the efficacy of ZOLPIDEM on any sleep measure. This edge is about the orexin/monoamine arm of arousal, not all sedation. PMC4801942

Mood (serotonin) increases it.

10.1038/s41598-021-92913-6 — the serotonergic dorsal raphe is wake-active — which surprises people who associate serotonin with rest. The cleanest demonstration is also the oldest and simplest: cooling of the nucleus raphe DORSALIS induces sleep in the CAT. Reduce that nucleus’ activity and the animal falls asleep. Converging: an orexin-2-selective antagonist reduced Fos-positive serotonergic neurons in the dorsal raphe alongside its hypnotic effect. The GABAergic VLPO neurons inhibit both the orexin system and the ascending arousal system; the arousal nuclei inhibit the VLPO back. A flip-flop has no comfortable middle — which is why sleep onset is abrupt rather than gradual, and why these arrows are drawn inhibitory as a class. doi 10.1038/s41598-021-92913-6

Memory chemical increases it.

Conditional, because the experiment that establishes it also splits sleep in two. Cholinergic cells in the basal forebrain and pontomesencephalic nuclei are wake-active. The dissociation is exact: ablation of basal forebrain cholinergic neurons attenuated the orexin-antagonist-induced increase in NREM sleep time without affecting REM sleep, while ablating locus coeruleus norepinephrine OR tuberomammillary histamine neurons attenuated REM promotion without affecting NREM. One drug, two sleep stages, two separate cell populations delivering the effect. A claim about improving sleep that does not say which stage is under-specified. PMC4801942

Motivation reduces it.

The dopaminergic ventral tegmental area is listed among the wake-active brain areas alongside the locus coeruleus, dorsal raphe, basal forebrain, posterior hypothalamus and orexin cells. The GABAergic VLPO neurons inhibit both the orexin system and the ascending arousal system; the arousal nuclei inhibit the VLPO back. A flip-flop has no comfortable middle — which is why sleep onset is abrupt rather than gradual, and why these arrows are drawn inhibitory as a class. Drawn from the consensus inventory, not from a lesion. PMC7851648

Quiets overexcitation reduces it.

Glutamate is an important mediator in waking mechanisms and has a widespread influence on the sleep-wake regulatory system, with glutamate levels increasing during wakefulness. And it is the substrate for the other side of the switch: GABA is synthesized from glutamate by glutamic acid decarboxylase, so the excitatory and inhibitory arms of sleep regulation share a precursor — the GABA → Sleep link is already drawn here. Rising with wakefulness is an observation, not a mechanism: no retrieved study manipulated glutamate and measured sleep. Weak accordingly. PMC7851648

Brain inflammation reduces it.

10.1186/1742-2094-9-91 — give it: administration of exogenous IL-1-beta OR TNF-alpha induces increased NREM sleep and enhances EEG delta power. Block it: inhibition of IL-1 OR TNF — by soluble receptors or IL-1 receptor antagonist — suppresses spontaneous sleep. Not just induced sleep; the ordinary kind. And it runs on a daily rhythm, which separates a regulator from a side effect: there is a diurnal rhythm of TNF-alpha and IL-1-beta mRNA in brain with highest levels occurring during peak sleep periods. The authors call TNF an endogenous SOMNOGEN. Two reversals in the conditional. Stage: these cytokines raise NREM and reduce REM — the stereotyped sleep of illness is described as an evolutionarily conserved NEUROIMMUNE adaptation, not an incidental consequence. Dose: low doses of IL-1 increase NREM at night while high doses suppress NREM during the day. More is not more. REFUTED ON A SECOND READING. This link was shown by linked steps until a source was opened that does not support it: “TNFα or IL1β injection enhances non-rapid eye movement sleep.” — Involvement of cytokines in slow wave sleep. Progress in Brain Research, 2011, 193, 39-47. doi:10.1016/b978-0-444-53839-0.00003-x | PMID 21854954 |. doi 10.1186/1742-2094-9-91 · PMID 21854954 · PMC3645329

It reduces Blood pressure.

Losing a night of sleep raises blood pressure — shown in a blinded, randomized crossover in healthy adults: 82±8 mmHg after normal sleep versus 86±7 after a night awake (p=0.012) (Hypertension 2000;35:1173, PMID 10818083). But not by the mechanism everyone assumes, and the same study is why we do not draw a the Sleep → Sympathetic link: measured directly by microneurography, muscle sympathetic nerve activity fell (28±6 to 22±6 bursts/min, p=0.017), and the authors conclude the pressor response is not mediated by sympathetic vasoconstriction or tachycardia. Reviews of the gold-standard recordings agree that full-night deprivation does not raise, and may lower, tonic sympathetic outflow — shifting the baroreflex set-point instead (PMC10751264). What is raised is sympathetic reactivity to a stressor, and in older adults the MSNA rise appears only in women. PMID 10818083 · PMC10751264

It increases Growth hormone.

GH release is pulsatile and sleep is named among the principal physiological regulators of GH secretion alongside food, exercise, fasting, age and body composition (Endotext NBK279056). Peak release occurs during slow-wave sleep; roughly two-thirds of daily GH output occurs at night, with about 70 percent of that in the first slow-wave episode.

It reduces Calm under stress.

The relationship is a loop, not an arrow, and the loop is the pathology: sleep disturbance activates inflammatory pathways and heightens stress reactivity, while persistent disturbance is associated with elevated CRP and IL-6; together these sustain a vicious cycle of hyperarousal and low-grade inflammation that transforms an adaptive short-term response into a chronic pathological process. Acute is not chronic, and the source is explicit: acute deprivation alone does not reliably raise these markers — one bad night is not the mechanism; persistence is. Mechanism at the cell level: chronic stress and sleep disruption bias microglia toward a pro-inflammatory state and alter astrocytic functions that gate sleep and metabolic clearance; chronic fragmentation also impairs glymphatic transport, which is enhanced during deep sleep. doi 10.1371/journal.pmen.0000531

It increases Social bonding hormone.

Turning the neurons back on with light reverses the deficit. PMC12137621

It increases Sustained focus.

The dose-response is clean, in 48 healthy young adults, in a laboratory, for 14 days: participants were randomized to 4, 6 or 8 hours time in bed, against a group given 3 days of total sleep deprivation, with a 10-minute psychomotor vigilance test administered repeatedly. At 8 hours, lapses of attention were relatively rare and stable. At 6 and 4 hours there was a steady build-up of vigilant attention deficits in a sleep dose-response manner — and impairment in the 4-hour condition reached levels equivalent to two to three days of acute total sleep deprivation. Two weeks at four hours performs like two days awake. And here is the part that matters most: the subjective signal decouples from the objective one. There was NO steady build-up of self-reported sleepiness and NO systematic dose-response effect on it — subjective sleepiness in the 4- and 6-hour conditions stabilized at a much lower level than in the total-deprivation group. Performance kept falling; the feeling of impairment did not. You cannot detect your own attention deficit on chronic short sleep, which means self-report is worthless as a guide and anyone judging a focus product by how alert they feel is reading the wrong instrument. The mechanism was then seen directly in human neurons: intracranial electrodes in neurosurgical patients performing a vigilance task after a night of sleep deprivation showed selective neuronal lapses preceding the behavioral lapses, with regional sleep-like slow and theta waves occurring during wakefulness. Parts of the brain go offline while the person is awake and does not know it. doi 10.1038/nm.4433 · PMID 31176308

It reduces Attention regulation.

The numbers ARE not marginal: insomnia and sleep disturbances affect up to 80 percent of adults with ADHD and up to 82 percent of children. Delayed sleep-wake timing occurs in up to 78 percent, and delayed sleep phase disorder is reported in 73-78 percent of children and adults with the diagnosis. Up to 44 percent have restless legs syndrome or RLS-like symptoms. And the direction is unresolved, which is recorded rather than papered over: ADHD is either the cause OR the consequence of sleep disturbances, OR they may have a shared aetiological and genetic background. Note also: sleep disruption itself may produce ADHD-like symptoms, and daytime RLS features such as restlessness and inattention mimic ADHD — so some of the diagnosed population may be carrying a sleep disorder wearing an attention label. doi 10.1007/s12402-018-0271-z · PMC12728042

It increases Mood.

Conditional, because chronic loss and one deliberate night do opposite things. Chronic: major depression involves increased sleep fragmentation, disinhibition of REM sleep and decreased slow-wave sleep, with reduced slow-wave amplitude possibly reflecting impaired plasticity, and a sleep phase delay with onset between 2AM and 6AM. Acute: one night of total sleep deprivation is a rapid-acting antidepressant, used clinically alongside light therapy and phase advance, the effect correlating with modulation of slow-wave activity. The practical reading matters: this is not licence to lose sleep. The deprivation effect is transient and is deployed under supervision alongside phase-shifting to hold the gain; chronic short sleep is on the other arm entirely. PMC12916475

It reduces Supports weight management.

The numbers ARE specific and the design is good: 1,024 volunteers from the Wisconsin Sleep Cohort, each measured by nocturnal polysomnography rather than self-report, with morning fasted bloods. Short sleep was associated with low leptin — A predicted 15.5 percent lower leptin for habitual sleep of 5 hours versus 8 — and high ghrelin, a predicted 14.9 percent higher ghrelin for polysomnographic sleep of 5 hours versus 8, independent of BMI. The two hormones move in opposite directions and both point the same way: leptin (satiety) falls, ghrelin (hunger) rises. This is not a story about tired people snacking — the hormonal signal itself has shifted, and it shifted independent of BMI. And the shape is A U, not a line: A U-shaped CURVILINEAR association between sleep duration and BMI was observed, with the proportional relationship holding in persons sleeping less than 8 hours, which was 74.4 percent of the sample. More sleep is not monotonically better. Cross-sectional cohort: the authors state they plan intervention studies, which is an admission that this design cannot establish direction. doi 10.1371/journal.pmed.0010062 · PMC535701

It increases Body clock.

It was the control condition in a study designed to test something else, which is often where the cleanest result hides. Investigators acclimatised mice to scheduled feeding over three months in constant darkness, removing the light-dark cycle entirely, then asked what predicted peripheral clock phase. The answer was not the food: peripheral clock phases were better predicted by the rest-activity cycle than by the food schedule, contrary to expectation based on time-restricted-feeding studies. Now the Sleep → Circadian Rhythm link closes it. The clock sets the sleep-wake cycle and the sleep-wake cycle feeds back on the clock. an association within a controlled experiment, not a manipulation of sleep followed by measurement of the clock. The rest-activity cycle also carries body temperature, corticosterone and locomotor signals that were not separated — and the HPA Axis / Cortisol → Circadian Rhythm link and the Exercise → Circadian Rhythm link are drawn independently. PMID 33158435 · PMC7646075

It reduces Daily energy.

sleep problems measured at 12 weeks were also found to mediate part of the effect of CBT and get on fatigue at 1-year follow-up, when compared to standard medical care. doi 10.3389/fpsyg.2018.01764 · PMC7260280

It increases Brain adaptability.

chemogenetic enhancement of cAMP during the period of sleep deprivation prevents deficits in a persistent form of long-term potentiation that is induced at the Schaffer collateral synapses in the hippocampal CA1 region. doi 10.1152/jn.2002.88.2.1073 · PMC9829098

It increases Memory & focus.

Named among the core mechanisms across six reviews of cognitive aging and synaptic plasticity: neurotransmitter systems, calcium signaling, neurotrophic support, cellular signaling pathways, and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. doi 10.1007/s10522-025-10300-4 · PMC6685093

It increases Restores fullness signal.

Sleep deprivation has been associated with multiple physiological changes, including increased cortisol and ghrelin levels, decreased leptin levels and impaired glucose metabolism. The pairing is the point: leptin down and ghrelin up simultaneously - satiety signal falls while hunger signal rises. Not one lever, two moving in opposite directions. doi 10.1016/j.smrv.2011.05.001 · PMC3132857

It increases Insulin sensitivity.

Sleep abnormalities were causally linked to impairments in glucose homeostasis, metabolic syndrome and type 2 diabetes mellitus, and neuro-hormonal changes accompanying behavioral sleep deprivation may lead to insulin resistance. Sleep duration is reported to have shortened from 8 to 6.5 hours over recent decades alongside the rise in obesity and diabetes - the reviewers treat that as hypothesis-generating, not proof. doi 10.1016/j.smrv.2011.05.001 · PMC3132857

Lipolytic (Stored-Fat Mobilization) →

Rewire (Total Brain Reset) →

Trinity (Mind Body Spirit Harmonizer) →

Anti-Fatigue (Cellular Energy Endurance) →

Event Horizon (Post-Ethanol Restoration) →

Hypnotic Sleep (Slow-Wave Architecture) →

Endurance Eternal (Pigment Preservation) →

Niagra (Desire, Arousal & Climax) →

Appetite Suppressant (Hunger Signal Control) →

Helico (Gastric Colonization Defense) →

Thunder (Erectile Performance) →

Male Fertility (Seminal Quality) →

Ecstatic (Nervous System Stand-Down) →